MCL1 and melanoma: Treatment of melanoma cells with two specific69,70 and potent MCL1 inhibitors ABBV-46771 and UMI-7735,72,73, resulted in inhibition of mTORC1 in dose- and time- dependent manner (Fig. 6A–F).